Bictegravir/emtricitabine/tenofovir alafenamide vs Oseltamivir phosphate
National NHS prescribing compared (Prescription Cost Analysis)
Oseltamivir phosphate was dispensed 112.0× as often as Bictegravir/emtricitabine/tenofovir alafenamide in May 2026 — 336 items versus 3 in England.
3items
Bictegravir/emtricitabine/tenofovir alafenamide · May 2026
NHSBSA Prescription Cost Analysis
336items
Oseltamivir phosphate · May 2026
NHSBSA Prescription Cost Analysis
Figure 1. Bictegravir/emtricitabine/tenofovir alafenamide versus Oseltamivir phosphate: national items dispensed by month
▬ Bictegravir/emtricitabine/tenofovir alafenamide · ╌ Oseltamivir phosphate
Source: NHSBSA Prescription Cost Analysis, to May 2026
| Measure | Bictegravir/emtricitabine/tenofovir alafenamide | Oseltamivir phosphate |
|---|---|---|
| Items, May 2026 | 3 | 336 |
| Items, last 12 months | 42 | 37,292 |
| Net ingredient cost, May 2026 | £2,639 | £5,074 |
See the full profile for Bictegravir/emtricitabine/tenofovir alafenamide or Oseltamivir phosphate.